ELI LILLY AND COMPANY Repayments of Short-term Debt
ELI LILLY AND COMPANY (LLY) reported Repayments of Short-term Debt of $3.70 million for the 3-month period ending 2021-03-31, per its 10-Q filed 2022-04-29.
Discontinued › Cash Flow › Financing Activities
us-gaap:RepaymentsOfShortTermDebt · last filed 2022-04-29
- ELI LILLY AND COMPANY repayments of short-term debt for the quarter ending 2021-03-31 was $3.70M.
- ELI LILLY AND COMPANY repayments of short-term debt for the quarter ending 2020-09-30 was $678.90M.
| Period end | Repayments of Short-term Debt 3 month | Repayments of Short-term Debt 6 month | Repayments of Short-term Debt 9 month |
|---|---|---|---|
| 2021-03-31 | $3.70M 10-Q · filed 2022-04-29 | ||
| 2020-09-30 | $678.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-10-27 | $914.30M 10-Q · filed 2021-10-27 | |
| 2020-06-30 | $235.40M 10-Q · filed 2021-08-03 | ||
| 2018-09-30 | $2.30B 10-Q · filed 2019-10-25 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Akari Therapeutics Plc (AKTX) | $1,527.991B | -47,921.42 | |
| JOHNSON & JOHNSON (JNJ) | United States | $652.528B | 29.10 |
| AbbVie Inc. (ABBV) | United States | $468.180B | 70.37 |
| Merck & Co., Inc. (MRK) | United States | $365.215B | 99.96 |
| ABBOTT LABORATORIES (ABT) | United States | $176.045B | 28.47 |
| PFIZER INC (PFE) | United States | $162.042B | 31.94 |
| VERTEX PHARMACEUTICALS INC / MA (VRTX) | United States | $132.481B | 28.56 |
| BRISTOL MYERS SQUIBB CO (BMY) | United States | $125.637B | 12.67 |
| REGENERON PHARMACEUTICALS, INC. (REGN) | United States | $74.751B | 21.53 |
| ALNYLAM PHARMACEUTICALS, INC. (ALNY) | United States | $33.420B | 54.94 |